Historical record - last NADAC effective date: 2/22/2017

Product Information

ONDANSETRON HCL 8 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2527 per EA under NDC 65862018805. Its NADAC has been published 170 times since Nov 28, 2013.

FDA first approved this application on Jul 31, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ONDANSETRON HCL 8 MG TABLET

Ondansetron Hydrochloride
$0.2527per EA

Strength

8 mg/1

NDC

65862018805

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

2/22/2017

Active Ingredients

ONDANSETRON HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078539

FDA Approved

7/31/2007

TE Code

AB

On Market Since

7/31/2007

Pharmacological Classes

Serotonin 3 Receptor Antagonists
Serotonin-3 Receptor Antagonist

Price Statistics

The NADAC for ONDANSETRON HCL 8 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has risen 68.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2527 per EA
All-time high$0.4333 (Jul 16, 2014)
All-time low$0.1503 (Nov 28, 2013)
Median price$0.2845
Average price$0.3024
Largest weekly change+111.5% (Jan 22, 2014)
Weeks tracked170
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+68.1%

Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 68% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ONDANSETRON HCL 8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON HCL 8 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2527 per EA (NDC 65862018805), effective Feb 22, 2017.

How has the price of ONDANSETRON HCL 8 MG TABLET changed over time?

Over the history we have for it, the NADAC for ONDANSETRON HCL 8 MG TABLET has risen 68.1%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ONDANSETRON HCL 8 MG TABLET?

Since Nov 28, 2013, the NADAC for ONDANSETRON HCL 8 MG TABLET has ranged from a low of $0.1503 (Nov 28, 2013) to a high of $0.4333 (Jul 16, 2014), with a median of $0.2845 per EA.

Are there cheaper alternatives to ONDANSETRON HCL 8 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ONDANSETRON HCL 8 MG TABLET, is $0.0812 per EA — about 68% below ONDANSETRON HCL 8 MG TABLET.

Who manufactures ONDANSETRON HCL 8 MG TABLET?

ONDANSETRON HCL 8 MG TABLET (NDC 65862018805) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.